急诊分诊工具预测COVID-19成人患者需强化呼吸或血管加压支持的价值
该研究纳入2021年4月1日至6月30日期间急诊就诊的677例COVID-19成人患者,计算WHO评分、CRB-65、DS-CRB 65、PMEWS、NEWS2和qSOFA,用ROC曲线比较各工具预测7天内IRVS需求和死亡的能力。结果显示PMEWS预测IRVS的AUC最高(0.830),其次为NEWS2(0.805);PMEWS以6.5分为界值预测IRVS的敏感度74.2%、特异度78.3%;预测7天死亡的AUC为0.802(0.766-0.839)。qSOFA预测IRVS(AUC 0.645)和7天死亡(AUC 0.677)表现较差。作者认为PMEWS可用于急诊COVID-19患者的分诊。
要点
- PMEWS预测IRVS的AUC为0.830,高于NEWS2的0.805,为各工具中最高。
- PMEWS以6.5分为界值预测IRVS:敏感度74.2%、特异度78.3%。
- PMEWS预测7天死亡的AUC为0.802(95%CI 0.766-0.839)。
- qSOFA预测IRVS的AUC为0.645、预测7天死亡的AUC为0.677,表现较差。
- 糖尿病(p=0.001)、高血压(p=0.001)、慢性肾脏病(p=0.04)与需要IRVS显著相关;从急诊到需要IRVS的时间越长,死亡可能性越高。
适用人群与场景
- 2021年4月1日至6月30日期间到急诊就诊的COVID-19成人患者,共677例。
诊断标准与关键阈值
- PMEWS以6.5分为界值预测需要IRVS:敏感度74.2%、特异度78.3%。
研究设计与关键结果
- 研究类型为急诊就诊COVID-19成人患者的评分预测研究,样本量677例,比较WHO评分、CRB-65、DS-CRB 65、PMEWS、NEWS2和qSOFA预测7天内IRVS需求和死亡的能力。
- PMEWS预测IRVS的AUC最高(0.830),其次为NEWS2(0.805);qSOFA预测IRVS的AUC为0.645。
- PMEWS预测7天死亡的AUC为0.802(95%CI 0.766-0.839);qSOFA预测7天死亡的AUC为0.677。
- 糖尿病(p=0.001)、高血压(p=0.001)、慢性肾脏病(p=0.04)与需要IRVS显著相关。
- 年龄、症状持续时间、脉率、呼吸频率、室内空气饱和度、入院时精神状态及需要IRVS的时间被确定为院内死亡的独立预测因素;从急诊到需要IRVS的时间越长,死亡可能性越高。
证据类型、等级与局限
- 证据类型:急诊就诊COVID-19成人患者的评分预测研究;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为PMEWS可用于急诊COVID-19患者的分诊,能准确预测需要IRVS和7天死亡。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Serum and radiological parameters used to predict prognosis in COVID patients are not feasible in the Emergency Department. Due to its damaging effect on multiple organs and lungs, scores used to assess multiorgan damage and pneumonia such as Pandemic Medical Early Warning Score (PMEWS), National Early Warning Score 2 (NEWS2), WHO score, quick Sequential Organ Failure Assessment (qSOFA), and DS-CRB 65 can be used to triage patients in the Emergency Department. They can be used to predict patients with the highest risk of seven-day mortality and need for intensive respiratory or vasopressor support (IRVS).
PURPOSE: The primary purpose was to find the score with the highest AUC in predicting IRVS and mortality at seven days. Additional objective was to find out any independent factors associated with IRVS and mortality.
METHODS: The data of adult patients who presented to the Emergency Department (ED) between April 1, 2021 and June 30, 2021 were collected. The WHO score, CRB-65, DS-CRB 65, PMEWS, NEWS2, and qSOFA score were calculated for all patients. Statistical analysis was done and an ROC curve was calculated for all the tools for mortality and need for IRVS at seven days.
FINDINGS: 677 patients presented to the Emergency Department with COVID-19 during the period above. Presence of Diabetes Mellitus (p = 0.001), Hypertension (p = 0.001), and chronic kidney disease(CKD) (p = 0.04) was significantly associated with need for IRVS. Age, duration of symptoms, pulse rate, respiratory rate, room air saturation, mental status at admission, and time to IRVS need were identified as independent predictors of in-hospital mortality. The longer the time to IRVS need from ED arrival, the higher the likelihood of mortality. PMEWS (0.830) had the highest AUC, followed by NEWS2 (0.805). A PMEWS cut-off of 6.5 was 74.2% sensitive and 78.3% specific in predicting the need for IRVS. ROC analysis to predict 7-day mortality showed that PMEWS had an AUC of 0.802 (0.766-0.839). QSOFA performed poorly in predicting IRVS (AUC 0.645) and 7-day mortality (AUC 0.677).
CONCLUSION: PMEWS may be used for triaging patients presenting to the Emergency Department with COVID-19 and accurately predicts the need for IRVS and seven day mortality.
参考来源
- Deva A, Juthani R, Kugan E, et al. Utility of ED triage tools in predicting the need for intensive respiratory or vasopressor support in adult patients with COVID-19. Am J Emerg Med. 2024. PMID: 38281375. doi:10.1016/j.ajem.2024.01.034
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。